PubMed:32716836
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 56-64 | SP_7 | denotes | COVID-19 |
T2 | 122-169 | SP_7 | denotes | severe acute respiratory syndrome coronavirus 2 |
T3 | 135-146 | UBERON:0001004 | denotes | respiratory |
T4 | 171-181 | SP_7 | denotes | SARS-CoV-2 |
T5 | 492-497 | UBERON:0000948 | denotes | heart |
T6 | 646-662 | CHEBI:35705 | denotes | immunosuppressed |
T7 | 646-662 | CHEBI:35705 | denotes | immunosuppressed |
T8 | 693-703 | UBERON:0002405 | denotes | autoimmune |
T9 | 753-764 | NCBITaxon:11118 | denotes | Coronavirus |
T10 | 779-787 | SP_7 | denotes | COVID-19 |
T11 | 853-863 | CL:0000775 | denotes | neutrophil |
T12 | 864-875 | GO:0005737 | denotes | cytoplasmic |
T13 | 876-884 | GO:0042571 | denotes | antibody |
T14 | 987-995 | SP_7 | denotes | COVID-19 |
T15 | 1212-1220 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 492-497 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T2 | 853-863 | Body_part | denotes | neutrophil | http://purl.org/sig/ont/fma/fma62860 |
T3 | 864-875 | Body_part | denotes | cytoplasmic | http://purl.org/sig/ont/fma/fma66835 |
T4 | 876-884 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 492-497 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 18-44 | Disease | denotes | ANCA-associated vasculitis | http://purl.obolibrary.org/obo/MONDO_0012105|http://purl.obolibrary.org/obo/MONDO_0015492 |
T3 | 34-44 | Disease | denotes | vasculitis | http://purl.obolibrary.org/obo/MONDO_0018882 |
T4 | 56-64 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 106-116 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 122-169 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 122-155 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 171-179 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 468-480 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T10 | 482-490 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T11 | 492-505 | Disease | denotes | heart disease | http://purl.obolibrary.org/obo/MONDO_0005267 |
T12 | 693-712 | Disease | denotes | autoimmune diseases | http://purl.obolibrary.org/obo/MONDO_0007179 |
T13 | 753-777 | Disease | denotes | Coronavirus Disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T14 | 779-787 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T15 | 885-913 | Disease | denotes | (ANCA)-associated vasculitis | http://purl.obolibrary.org/obo/MONDO_0012105|http://purl.obolibrary.org/obo/MONDO_0015492 |
T17 | 903-913 | Disease | denotes | vasculitis | http://purl.obolibrary.org/obo/MONDO_0018882 |
T18 | 987-995 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T19 | 1107-1133 | Disease | denotes | ANCA-associated vasculitis | http://purl.obolibrary.org/obo/MONDO_0012105|http://purl.obolibrary.org/obo/MONDO_0015492 |
T21 | 1123-1133 | Disease | denotes | vasculitis | http://purl.obolibrary.org/obo/MONDO_0018882 |
T22 | 1174-1200 | Disease | denotes | ANCA-associated vasculitis | http://purl.obolibrary.org/obo/MONDO_0012105|http://purl.obolibrary.org/obo/MONDO_0015492 |
T24 | 1190-1200 | Disease | denotes | vasculitis | http://purl.obolibrary.org/obo/MONDO_0018882 |
T25 | 1212-1220 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 213-216 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T2 | 230-231 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 492-497 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T4 | 492-497 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T5 | 492-497 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T6 | 492-497 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T7 | 853-875 | http://purl.obolibrary.org/obo/CP_0000000 | denotes | neutrophil cytoplasmic |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 18-22 | Chemical | denotes | ANCA | http://purl.obolibrary.org/obo/CHEBI_34507 |
T2 | 886-890 | Chemical | denotes | ANCA | http://purl.obolibrary.org/obo/CHEBI_34507 |
T3 | 1107-1111 | Chemical | denotes | ANCA | http://purl.obolibrary.org/obo/CHEBI_34507 |
T4 | 1174-1178 | Chemical | denotes | ANCA | http://purl.obolibrary.org/obo/CHEBI_34507 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 34-44 | Phenotype | denotes | vasculitis | http://purl.obolibrary.org/obo/HP_0002633 |
T2 | 468-480 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T3 | 693-712 | Phenotype | denotes | autoimmune diseases | http://purl.obolibrary.org/obo/HP_0002960 |
T4 | 903-913 | Phenotype | denotes | vasculitis | http://purl.obolibrary.org/obo/HP_0002633 |
T5 | 1123-1133 | Phenotype | denotes | vasculitis | http://purl.obolibrary.org/obo/HP_0002633 |
T6 | 1190-1200 | Phenotype | denotes | vasculitis | http://purl.obolibrary.org/obo/HP_0002633 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 34-44 | Disease | denotes | vasculitis | MESH:D014657 |
3 | 56-64 | Disease | denotes | COVID-19 | MESH:C000657245 |
21 | 106-116 | Disease | denotes | infections | MESH:D007239 |
22 | 122-169 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
23 | 171-181 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
24 | 418-426 | Species | denotes | patients | Tax:9606 |
25 | 468-480 | Disease | denotes | hypertension | MESH:D006973 |
26 | 482-490 | Disease | denotes | diabetes | MESH:D003920 |
27 | 492-505 | Disease | denotes | heart disease | MESH:D006331 |
28 | 559-568 | Disease | denotes | mortality | MESH:D003643 |
29 | 663-671 | Species | denotes | patients | Tax:9606 |
30 | 693-712 | Disease | denotes | autoimmune diseases | MESH:D001327 |
31 | 753-777 | Disease | denotes | Coronavirus Disease 2019 | MESH:C000657245 |
32 | 779-787 | Disease | denotes | COVID-19 | MESH:C000657245 |
33 | 903-913 | Disease | denotes | vasculitis | MESH:D014657 |
34 | 987-995 | Disease | denotes | COVID-19 | MESH:C000657245 |
35 | 1123-1133 | Disease | denotes | vasculitis | MESH:D014657 |
36 | 1190-1200 | Disease | denotes | vasculitis | MESH:D014657 |
37 | 1212-1220 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-74 | Sentence | denotes | Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic. |
T2 | 75-331 | Sentence | denotes | Since the first description of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China in December 2019, it has evolved into a pandemic and emerged as an unprecedented worldwide crisis overwhelming healthcare systems globally. |
T3 | 332-569 | Sentence | denotes | Analysis of the available literature to date suggests that, in addition to older age, patients with underlying co-morbidities including hypertension, diabetes, heart disease are at higher risk for severe disease with increased mortality. |
T4 | 570-816 | Sentence | denotes | Practitioners around the world also have become increasingly concerned that immunosuppressed patients including those with autoimmune diseases may be at increased risk for developing Coronavirus Disease 2019 (COVID-19) with serious complications. |
T5 | 817-996 | Sentence | denotes | Very little is known about how anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis modifies the susceptibility, clinical presentation and disease course of COVID-19. |
T6 | 997-1230 | Sentence | denotes | In this review, we discuss the mechanism of action and challenges of the current therapeutic armamentarium of ANCA-associated vasculitis and outline approaches to management of ANCA-associated vasculitis during the COVID-19 pandemic. |